Delivra Health Brands Inc.
DHBUF
$0.12
-$0.01-4.18%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.75M | 2.33M | 3.15M | 2.16M | 1.97M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.75M | 2.33M | 3.15M | 2.16M | 1.97M |
| Cost of Revenue | 1.05M | 1.24M | 1.46M | 1.08M | 1.04M |
| Gross Profit | 697.20K | 1.09M | 1.69M | 1.08M | 924.40K |
| SG&A Expenses | 1.02M | 1.09M | 1.12M | 1.05M | 1.15M |
| Depreciation & Amortization | -- | 19.60K | 209.60K | 227.20K | 232.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.07M | 2.34M | 2.79M | 2.35M | 2.43M |
| Operating Income | -322.80K | -16.00K | 355.60K | -196.50K | -462.20K |
| Income Before Tax | -294.80K | -66.10K | 375.10K | -294.00K | -580.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -294.80K | -66.10K | 375.10K | -294.00K | -580.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -294.80K | -66.10K | 375.10K | -294.00K | -580.10K |
| EBIT | -322.80K | -16.00K | 355.60K | -196.50K | -462.20K |
| EBITDA | -322.80K | 3.60K | 565.20K | 30.70K | -229.30K |
| EPS Basic | -0.01 | 0.00 | 0.01 | -0.01 | -0.02 |
| Normalized Basic EPS | -0.01 | 0.00 | 0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.01 | 0.00 | 0.01 | -0.01 | -0.02 |
| Normalized Diluted EPS | -0.01 | 0.00 | 0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 31.26M | 31.26M | 31.26M | 31.26M | 31.26M |
| Average Diluted Shares Outstanding | 31.26M | 31.26M | 31.26M | 31.26M | 31.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |